Moreover, the most prevalent rheumatologic manifestations in the non-GATA2 mutated MDS group are vasculitis, namely polyarteritis nodosa and giant-cell arteritis, differently from GATA2 mutated patients (39, 40). This evidence concerns the gene GATA2 and myelodysplastic syndrome.